Overview

Hydroxychloroquine in Unexplained Recurrent Pregnancy Loss

Status:
Not yet recruiting
Trial end date:
2023-01-01
Target enrollment:
Participant gender:
Summary
To investigate efficacy and safety of Hydroxychloroquin in improving pregnancy outcome in women with unexplained recurrent pregnancy loss .
Phase:
Phase 1
Details
Lead Sponsor:
Ain Shams University
Treatments:
Aspirin
Hydroxychloroquine